Topic 10: Schizophrenia Flashcards
Define schizophrenia
Schizophrenia is a type of psychosis characterised by a profound disruption of cognition and emotion.
Types of schizophrenia
- Paranoid Sz - feels extremely suspicious or grandiose.
- Catatonic Sz - person is withdrawn, mute, negative and often assumes very unusual body positions.
- Hebephrenic/disorganised Sz - primarily negative symptoms.
- Undifferentiated Sz - exhibits the characteristics of Sz but the overall picture is not one of catatonic type, paranoid type, or disorganised type Sz.
- Residual Sz - A subtype of schizophrenia in which the individual has suffered an episode of Sz but there are no longer any delusions, hallucinations, disorganized speech or behaviour.
Negative symptoms of schizophrenia
Negative symptoms appear to reflect a diminution or loss of normal functioning.
Examples:
- Speech poverty/alogia - The lessening of speech fluency & productivity, which reflects slowing or blocked thoughts.
- Avolition - The reuction, difficulty, or inability to initiate and persist in goal-directedbehaviour (lack of drive & motivation).
- Affected flattening - A reduction in the range & intensity of emotional expression, including facial expression, voice tone, eye contact & body language.
- Anhedonia - Loss of enjoymnet of activities that were previously pleasurable.
- Asociality - social withdrawal
Positive symptoms of schizophrenia
Positive symptoms appear to reflect an excess or distortion of normal function.
Examples:
- Hallucinations - Disotortions or exaggerations in any of the senses, most notably auditory hallucinations (A pereception of things that are not present).
- Delusions - fasle, sustained beliefs, which match reality. Delusions of grandeur = False, sustained beleif of importance or superiority. Delusions of persecution = False, sustained belief that others are trying to inflict suffering.
- Echolalia - Pathological repetition of the words of others.
- Disorganised thinking - can be speech, thinking or behaviour. Difficulties concentrating on things.
Diagnosing schizophrenia
Clinicians can use two diagnostic manuals: DSM and ICD
2 symptoms need to be present for 6 months or more & active for at least one month before a person can be diagnosed with scizophreniaa.
Measuring reliability of diagnosis
Reliability is measured by:
- Intra-rater reliability = How consistent one clinician is in diagnosing symptoms (test-retest).
- Inter-rater reliability = How similar diagnosis is between clinicians (measured by a statistic called a kappa score - 0.7 or above is considered good reliability.
Evaluation/discussion into reliability of diagnosis
- In 1962, Beck found that diagnosis between different doctors were 52% similar, however measures of inter-rater reliability made in 2005 found that the diagnosis of Sz were 81% similar, so reliability has increased over time.
- Whaley (2001) found inter-rater reliability correlations in the diagnostic of schizophrenia as low as 0.11.
- Rosenhan (1973) - ‘normal’ pps presented themselves to US psychiatric hospitals claiming they heard an unfamiliar voice in their head saying ‘empty’, ‘hollow’, and ‘thud’. They were all diagnosed as having schizophrenia and admitted, and throughout their stay, none of the staff recognised that they were not actuallly displaying symptoms of Sz. Highlights lack of care & challenges reliability.
- Cultural differences in diagnosis: Copeland gave 134 US & 194 British psychiatrists a description of a patient. 69% of the US psychiatrists diagnosed Sz but only 2% of the British ones gave the same diagnosis. This suggests a lack of consistency between American and British clinicians in diagnosing SZ. It also shows low concurrent validity between the DSM-V (primarily used in thd US) and the ICD (primarily used in the UK), suggesting that either one, or both, of the manuals are incorrectly measuring schizophrenia.
- In the DSM-V field trials (Regier et al, 2013) the diagnosis of Sz had a kappa score of only 0.46.
Problems with the validity of diagnosis
- Symptom overlap refers to the fact that symptoms of a disorder may not be unique to that disorder but may also be found in other disorders (many symptoms of schizophrenia are also found in other disorders, such as depression or bipolar disorder), making accurate diagnosis difficult.
- co-morbidity refers to the extent that two (or more) conditions ot diseases occur simultaneously in a patient. Substance abuse, anxiety and depression are common psychiatric co-morbitities among patients with Sz. Comorbidity can make it difficult to tell the difference between schizophrenia and other conditions, such as depression.
Evaluation/discussion of validity in diagnosis
- Gender bias: Loring and Powell randomly selected 290 M & F psyhciatrists to offer their judgements on an account of patients’ behaviour. When patients were described as ‘male’ or their gender wasn’t shared, 56% gave a diagnosis of Sz. When patients were described as ‘female’, only 20% were given a diagnosis - alpha bias.
- Co-morbidity: Buckley et al estimate that co-morbid depression occurs in 50% of Sz patients, and 47% of patients have a lifetime diagnosis of co-morbid substance abuse. A meta-analysis by Swets et al found that at least 12% of sZ patients also fulfilled the diagnostic criteria for OCD. Weber looked at nearly 6 million hospital discharge records and found evidence of many co-morbid non-psychiatric diagnoses including asthma, hypertension & type 2 diabetes.
- Lacks predicitve validity - Variation in prognosis: Harrison (2001) found that 30% of patients showed improvement in some cases, but only 10% in others.
- Cultural Bias: Cochrane conducted a review comparing the number of people diagnosed with Sz in Britian and the Caribbean. The overall rate of Sz was similar in the Caribbean and in Britian. Afro-Caribbean people were 7x more likely to be diagnosed with Sz when living in Britian than when living in the Caribbean. Cochrane concluded that this was because of culture bias by British doctors.
Measuring validity of diagnosis
- The extent that a diagnosis actually reflects the actual disorder (how accurate the DSM/ICD is).
- The extent which different assessement systems arrive at the same diagnosis for the same patient.
Cheniaux (2006)
- 2 idependent psychiatrists diagnosede 100 patients using both DSM & ICD.
Number of diagnosed schizophrenia cases: - 26 & 13 DSM = Lack of consistency between psychiatrists & therefore inter-rater reliability
- 44 & 24 ICD
There’s a discrepency between the number of diagnosis by DSM compared to ICD challenging the validity of the manuels.
Biological Explanation for schizophrenia: Genetics
Family Studies
Gottesman
- Children with 2 parents with Sz = 46% CR
- Children with 1 parent with Sz = 13% CR
- Siblings (where one has Sz) = 9% CR
Biological Explanation for schizophrenia: Genetics
Twin studies
Gottesman
- CR for Mz twins = 48%
- CR for Dz twins = 17%
- General population = 1% risk
Eval:
If your romantic partner has Sz, your risk is twice that of the general population (2%). This suggest environment plays a role as they’re not genetically related.
Mz twins are often treated more similarly, encounter similar environments & experience more identity confusion that Dz twins. Differences in CR’s may reflect environmental differences between the two types of twins.
Biological Explanation for schizophrenia: Genetics
Adoption Studies
Tienari et al
Of the 164 adoptees whose biological mothers had Sz, 11 (6.7%) also received a Sz diagnosis, compared to just 4 (2%) of the 197 control adoptees. Shows genetic liability to Sz.
Eval:
Adoptees may be selectively placed. A large adoption study into Sz took place in Oregon (1966), where it was assumed that procreation by any person admitted to a mental hospital would produce offspring with an inherited tendency to ‘insanity’. Therefore it is unlikely that the children born to women with Sz would have been placed in the same type of adoptive families as children without such a background.
Ripke (2014)
Evidence that Sz is polygenic (a characteristic that is influenced by two or more genes).
P: He found the genetic makeup (genomes) of 37,000 patients and 113,000 controls.
F: 108 separate genetic variations were associated with increased risk of Sz. Link with genes which associated with number of neurotransmitters including dopamine.
Dopamine hypotheisis
Claims that an excess of the nuerotransmitter dopamine in certain areas of the brain is associated with the positive symptoms of scizophrenia.
Individuals with positive symptoms of Sz are likely to have high levels of dopamine and more dopamine receptors on the post-synaptic cell, increasing dopaminergic activity.
Th Revised dopamine hypothesis - Davis et al (1991):
Excess of dopamine in the mesolimbic pathway = positive symptoms
Deficit of dopamine in areas of prefrontal cortex (area responsible for thinking, decision making etc) = Negative symptoms
Neural correlates
Patterns of strucutre or function in the brain that correlate with a Sz experience. As they occur simultaneously this could lead us to believe that the patients observed are implicated in causing Sz.
Specific brain areas involved in Schizophrenia
- The prefrontal cortex: (controls planning reasoning and judgement) has been found to be impaired in Sz patients. Deficits in the PFC and it’s connections with other brain areas have been linked to cognitive symptoms of Sz. Patel et al (2010) used PET scans & found lower dopamine levels in dorsolateral prefrontal cortex of Sz patients compared to non-Sz controls. PET scans = controlled scientific evidence but doesn’t establish cause and effect
- The hippocampus: Several studies have reported anatomical changes in the hippocampus in Sz patients. Deficits in the nerve connections between the hippocampus and the PFC have been found to correlate with the degree of working memory impairments, a central cognitive impairment in Sz.
- Reduced volume of grey matter, especially in the temporal and frontal lobes.
- Reduced myelation of white matter pathways in Sz patients, compared to controls (Due et al). Particularly in the neural pathways between the hippocampus & PFC.
- Avolition has been asssociated with the ventral striatum (a reward centre in the brain). Juckel et al measured activity levels here & found lower levels of activity in those with Sz, compared to controls.
- Reduced activity in the superior temporal gyrus & the anterior cingulate gyrus is a neural correlate for auditory hallucinations. Allen et al scanned patients with auditory hallucinations, compared to a control. Lower activation levels were found in the hallucination group.
Hyperdopaminergia
Excessive levels of dopamine
Hypodopaminergia
Low levels of dopamine
Evaluation of dopamine hypothesis
Strengths:
- Practical Applications: Antipsychotic drugs, such as chlorpromazine, which reduce the symptoms of Sz work by inhibiting dopamine transmission. CP: Antipsychotic drugs only reduce all of the symptoms in around 20% of patients.
- Post-mortem (after death) examinations show schizophrenia patients have more dopamine receptors in the left amygdala (Falkai et al., 1988) and the caudate nucleus (Owen et al., 1978).
Weaknesses:
- There is some evidence to suggest that dopamine is not the only neurotransmitter involved. Moghaddam & Javitt found evidence for the role of an NT called glutamate in which it appeared that Sz patients have a deficiency in glutamate function. Supports biological/neural explanation but challenges the simplicity of dopamine hypothesis on its own.
- Antipsychotics gradually reduce positive symptoms over several weeks, despite immediately blocking dopamine receptors. Suggests it’s not a direct cause and effect and challenges the simplicity of the theory.
Anti-psychotics
- Drugs used for hyperdopaminergia to reduce positve Sz symptoms
- Typical (traditional) and atypical (newer)
- Examples: Chlorpromazinwe, clozapine, risperidone
Chlorpromazine
- Typical antipsychotic (1950s)
- Can be taken as tablets, syrups (absorbed faster than tablets), or injection.
- Blocks dopamine receptors, reducing dopaminergic activity.
- Reduced positive symptoms
- Also an effective sedative, often used to calm patients with Sz and other mental disorders.
- Side effects: dizziness, agitation, sleepiness, stiff jaw, weight gain, tardive dyskinesia, neruoleptic maligant syndrome (which can be fatal).
Clozapine
- Atypical antipsychotic (1970s)
- Binds to dopamine receptors & acts on serotonine & glutamine receptors, providing mood-enhancing effects & improving cognition. Important as 30-50% of Sz patients attempt suicide.
- Requires regular blood tests due to risk of fatal condition - agranulocytosis
- Not available as an injection